Palos, I., Lara-Ramirez, E. E., Lopez-Cedillo, J. C., Garcia-Perez, C., Kashif, M., Bocanegra-Garcia, V., . . . Rivera, G. (2017). Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies. Molecules.

Palos, Isidro, Edgar E. Lara-Ramirez, Julio Cesar Lopez-Cedillo, Carlos Garcia-Perez, Muhammad Kashif, Virgilio Bocanegra-Garcia, Benjamin Nogueda-Torres, et Gildardo Rivera. "Repositioning FDA Drugs As Potential Cruzain Inhibitors From Trypanosoma Cruzi: Virtual Screening, In Vitro and In Vivo Studies." Molecules 2017.

Palos, Isidro, et al. "Repositioning FDA Drugs As Potential Cruzain Inhibitors From Trypanosoma Cruzi: Virtual Screening, In Vitro and In Vivo Studies." Molecules 2017.